CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+10.99%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$10.6B
AUM Growth
+$1.15B
(+12%)
Cap. Flow
+$331M
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
858
New
50
Increased
272
Reduced
342
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
$99.4M |
| 2 |
Merck
MRK
|
$74.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$52.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
$36.6M |
| 5 |
Danaher
DHR
|
$36.3M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$86.9M |
| 2 |
Apple
AAPL
|
$60.7M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$31.9M |
| 4 |
Kimberly-Clark
KMB
|
$28.1M |
| 5 |
Arista Networks
ANET
|
$21.4M |
Sector Composition
| 1 | Healthcare | 35.9% |
| 2 | Technology | 20.42% |
| 3 | Consumer Discretionary | 9.53% |
| 4 | Communication Services | 7.72% |
| 5 | Financials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Infosys
INFY
$67.9B
| $3.42M | 0.03% |
247,978
-70,229
| -22% | -$970K |
|
402
Arcturus Therapeutics
ARCT
$485M
| $3.42M | 0.03% |
79,720
| – | – |
|
403
Atmos Energy
ATO
$26.7B
| $3.41M | 0.03% |
35,653
-1,475
| -4% | -$141K |
|
404
Freeport-McMoran
FCX
$66.5B
| $3.39M | 0.03% |
216,549
-211,709
| -49% | -$3.31M |
|
405
Ardelyx
ARDX
$1.57B
| $3.35M | 0.03% |
+637,643
| New | +$3.35M |
|
406
SSR Mining
SSRM
$4.28B
| $3.33M | 0.03% |
+179,086
| New | +$3.33M |
|
407
Global Payments
GPN
$21.3B
| $3.32M | 0.03% |
18,697
-749
| -4% | -$133K |
|
408
Capital One
COF
$142B
| $3.26M | 0.03% |
45,394
-16,583
| -27% | -$1.19M |
|
409
Truist Financial
TFC
$60B
| $3.26M | 0.03% |
85,598
-2,408
| -3% | -$91.6K |
|
410
Sun Life Financial
SLF
$32.4B
| $3.25M | 0.03% |
80,032
+28,433
| +55% | +$1.15M |
|
411
Intercontinental Exchange
ICE
$99.8B
| $3.25M | 0.03% |
32,432
-2,539
| -7% | -$254K |
|
412
Fiserv
FI
$73.4B
| $3.2M | 0.03% |
31,073
-2,395
| -7% | -$247K |
|
413
Pultegroup
PHM
$27.7B
| $3.18M | 0.03% |
68,662
-131,365
| -66% | -$6.08M |
|
414
Adverum Biotechnologies
ADVM
$73.9M
| $3.13M | 0.03% |
30,358
+7,500
| +33% | +$773K |
|
415
NIO
NIO
$13.4B
| – | – |
0
| – | – |
|
416
Take-Two Interactive
TTWO
$44.2B
| $3.1M | 0.03% |
18,758
-1,387
| -7% | -$229K |
|
|
VRAY
417
DELISTED
ViewRay, Inc.
VRAY
| $3.09M | 0.03% |
881,705
-33,899
| -4% | -$119K |
|
418
PACCAR
PCAR
$52B
| $3.08M | 0.03% |
54,182
-1,596
| -3% | -$90.7K |
|
419
Akero Therapeutics
AKRO
$3.58B
| $3.06M | 0.03% |
99,500
-58,500
| -37% | -$1.8M |
|
420
Dow Inc
DOW
$17.4B
| $3.04M | 0.03% |
64,559
-3,391
| -5% | -$160K |
|
421
Cytokinetics
CYTK
$6.34B
| $3.04M | 0.03% |
+140,225
| New | +$3.04M |
|
422
General Motors
GM
$55.5B
| $3.02M | 0.03% |
102,207
-3,626
| -3% | -$107K |
|
423
Sanofi
SNY
$113B
| $3.02M | 0.03% |
60,148
+8,916
| +17% | +$447K |
|
|
XYZ
424
Block, Inc.
XYZ
$45.7B
| $2.98M | 0.03% |
18,318
-1,938
| -10% | -$315K |
|
425
Cardinal Health
CAH
$35.7B
| $2.96M | 0.03% |
63,137
-43,961
| -41% | -$2.06M |
|